ACRE · Ares Commercial Real Estate Corporation Common Stock
View on chartInsiders & Stakes
| Tae Sik Yoon Chief Financial Officer | ▲ Buy | Grant | 289,153 Shares held | 12/11/2025 | View profile |
| Bryan Patrick Donohoe Chief Executive Officer | ▼ Sell | Open Market | 250,197 Shares held | 1/14/2026 | View profile |
| James E. Skinner Director | ▲ Buy | Grant | 116,217 Shares held | 4/29/2026 | View profile |
| Edmond N. Moriarty III Director | ▲ Buy | Grant | 98,905 Shares held | 4/29/2026 | View profile |
| Anton Feingold Gen. Counsel VP and Secretary | ▼ Sell | Open Market | 92,754 Shares held | 1/14/2026 | View profile |
| Jeffrey Michael Gonzales CFO and Treasurer | ▼ Sell | Open Market | 88,533 Shares held | 1/14/2026 | View profile |
| Rebecca Jaisali Parekh Director | ▲ Buy | Grant | 77,258 Shares held | 4/29/2026 | View profile |
| Caroline Blakely Director | ▲ Buy | Grant | 50,495 Shares held | 4/29/2026 | View profile |
| Benjamin William Stephen Director | ▲ Buy | Open Market | 36,596 Shares held | 2/23/2022 | View profile |
| William Browning Director | ▲ Buy | Grant | 25,053 Shares held | 4/29/2026 | View profile |
| Rand Scott April Director | ▲ Buy | Grant | 18,879 Shares held | 4/29/2026 | View profile |
Transaction History
| William Browning | ▲ Buy | Grant | 18,879 | $0 | 4/29/2026 |
| Caroline Blakely | ▲ Buy | Grant | 18,879 | $0 | 4/29/2026 |
| Rand Scott April | ▲ Buy | Grant | 18,879 | $0 | 4/29/2026 |
| Edmond N. Moriarty III | ▲ Buy | Grant | 18,879 | $0 | 4/29/2026 |
| James E. Skinner | ▲ Buy | Grant | 18,879 | $0 | 4/29/2026 |
| Rebecca Jaisali Parekh | ▲ Buy | Grant | 18,879 | $0 | 4/29/2026 |
| Bryan Patrick Donohoe | ▼ Sell | Open Market | 21,761 | $107K | 1/14/2026 |
| Jeffrey Michael Gonzales | ▼ Sell | Open Market | 6,218 | $31K | 1/14/2026 |
| Anton Feingold | ▼ Sell | Open Market | 7,606 | $37K | 1/14/2026 |
| Jeffrey Michael Gonzales | ▲ Buy | Grant | 44,000 | $0 | 12/11/2025 |
| Tae Sik Yoon | ▲ Buy | Grant | 37,400 | $0 | 12/11/2025 |
| Anton Feingold | ▲ Buy | Grant | 22,000 | $0 | 12/11/2025 |
| Bryan Patrick Donohoe | ▲ Buy | Grant | 49,500 | $0 | 12/11/2025 |
| Rebecca Jaisali Parekh | ▲ Buy | Grant | 24,696 | $0 | 4/29/2025 |
| Rand Scott April | ▲ Buy | Grant | 24,696 | $0 | 4/29/2025 |
| Edmond N. Moriarty III | ▲ Buy | Grant | 24,696 | $0 | 4/29/2025 |
| Caroline Blakely | ▲ Buy | Grant | 24,696 | $0 | 4/29/2025 |
| James E. Skinner | ▲ Buy | Grant | 24,696 | $0 | 4/29/2025 |
| William Browning | ▲ Buy | Grant | 24,696 | $0 | 4/29/2025 |
| Anton Feingold | ▼ Sell | Open Market | 7,615 | $43K | 1/31/2025 |
| Jeffrey Michael Gonzales | ▼ Sell | Open Market | 4,020 | $23K | 1/31/2025 |
| Bryan Patrick Donohoe | ▼ Sell | Open Market | 23,465 | $133K | 1/31/2025 |
| Jeffrey Michael Gonzales | ▲ Buy | Grant | 25,000 | $0 | 12/13/2024 |
| Anton Feingold | ▲ Buy | Grant | 17,000 | $0 | 12/13/2024 |
| Bryan Patrick Donohoe | ▲ Buy | Grant | 45,000 | $0 | 12/13/2024 |
| Tae Sik Yoon | ▲ Buy | Grant | 32,500 | $0 | 12/13/2024 |
| William Browning | ▲ Buy | Grant | 13,842 | $0 | 5/2/2024 |
| James E. Skinner | ▲ Buy | Grant | 13,842 | $0 | 5/2/2024 |
| Rebecca Jaisali Parekh | ▲ Buy | Grant | 13,842 | $0 | 5/2/2024 |
| Caroline Blakely | ▲ Buy | Grant | 13,842 | $0 | 5/2/2024 |
| Edmond N. Moriarty III | ▲ Buy | Grant | 13,842 | $0 | 5/2/2024 |
| Rand Scott April | ▲ Buy | Grant | 13,842 | $0 | 5/2/2024 |
| Bryan Patrick Donohoe | ▼ Sell | Open Market | 18,868 | $195K | 1/30/2024 |
| Anton Feingold | ▼ Sell | Open Market | 5,890 | $61K | 1/29/2024 |
| Anton Feingold | ▲ Buy | Grant | 21,000 | $0 | 12/13/2023 |
| Bryan Patrick Donohoe | ▲ Buy | Grant | 59,000 | $0 | 12/13/2023 |
| Tae Sik Yoon | ▲ Buy | Grant | 40,000 | $0 | 12/13/2023 |
| Rand Scott April | ▲ Buy | Grant | 10,711 | $0 | 4/21/2023 |
| James E. Skinner | ▲ Buy | Grant | 10,711 | $0 | 4/21/2023 |
| Rebecca Jaisali Parekh | ▲ Buy | Grant | 10,711 | $0 | 4/21/2023 |
| Edmond N. Moriarty III | ▲ Buy | Grant | 10,711 | $0 | 4/21/2023 |
| William Browning | ▲ Buy | Grant | 10,711 | $0 | 4/21/2023 |
| Caroline Blakely | ▲ Buy | Grant | 10,711 | $0 | 4/21/2023 |
| Anton Feingold | ▼ Sell | Open Market | 3,166 | $34K | 1/10/2023 |
| Bryan Patrick Donohoe | ▼ Sell | Open Market | 15,072 | $164K | 1/10/2023 |
| Tae Sik Yoon | ▲ Buy | Grant | 40,000 | $0 | 12/8/2022 |
| Anton Feingold | ▲ Buy | Grant | 19,500 | $0 | 12/8/2022 |
| Bryan Patrick Donohoe | ▲ Buy | Grant | 64,000 | $0 | 12/8/2022 |
| William Browning | ▲ Buy | Grant | 4,130 | $0 | 4/25/2022 |
| Rebecca Jaisali Parekh | ▲ Buy | Grant | 4,130 | $0 | 4/25/2022 |
| Caroline Blakely | ▲ Buy | Grant | 4,130 | $0 | 4/25/2022 |
| Edmond N. Moriarty III | ▲ Buy | Grant | 4,130 | $0 | 4/25/2022 |
| James E. Skinner | ▲ Buy | Grant | 4,130 | $0 | 4/25/2022 |
| Rand Scott April | ▲ Buy | Grant | 4,130 | $0 | 4/25/2022 |
| Anton Feingold | ▼ Sell | Open Market | 935 | $15K | 4/8/2022 |
| Benjamin William Stephen | ▲ Buy | Open Market | 18,000 | $253K | 2/23/2022 |
| Anton Feingold | ▼ Sell | Open Market | 1,415 | $21K | 1/18/2022 |
| Bryan Patrick Donohoe | ▼ Sell | Open Market | 8,813 | $132K | 1/18/2022 |
| Rebecca Jaisali Parekh | ▲ Buy | Grant | 5,000 | $0 | 12/16/2021 |
| Anton Feingold | ▲ Buy | Grant | 13,500 | $0 | 12/9/2021 |
| Tae Sik Yoon | ▲ Buy | Grant | 30,000 | $0 | 12/9/2021 |
| Bryan Patrick Donohoe | ▲ Buy | Grant | 52,500 | $0 | 12/9/2021 |
| Bryan Patrick Donohoe | ▲ Buy | Open Market | 3,509 | $50K | 3/10/2020 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 27, 2026
ACRE Faces Scrutiny Over High Dividend and Valuation
Recent articles highlight concerns about Ares Commercial Real Estate's 13.27% dividend yield, with one piece suggesting it is less sustainable than peers. Another notes the stock trades at a significant discount to book value. These discussions occur while the stock remains near its 52-week low, reflecting ongoing investor debate about the company's payout structure versus its valuation.
ACRE Faces Scrutiny Over High Dividend and Valuation. Recent articles highlight concerns about Ares Commercial Real Estate's 13.27% dividend yield, with one piece suggesting it is less sustainable than peers. Another notes the stock trades at a significant discount to book value. These discussions occur while the stock remains near its 52-week low, reflecting ongoing investor debate about the company's payout structure versus its valuation.